One year ago, when we were finalizing our outlook for 2020, the world was in the early throes of the COVID-19 pandemic. While we anticipated that 2021 would bring many new challenges, few, if any, of us predicted at the time...more
4/13/2021
/ Business Litigation ,
Coronavirus/COVID-19 ,
Corporate Governance ,
Corporate Sales Transactions ,
Forum Selection ,
Infectious Diseases ,
Material Adverse Effects ,
Publicly-Traded Companies ,
Securities Litigation ,
Securities Regulation ,
Shareholders
In recent weeks, the Co-Directors of the SEC's Enforcement Division warned of the "importance of maintaining market integrity" in these uncertain times. Specifically, they urged public companies to be mindful of Regulation FD...more
Our "2020 securities, shareholder, and M&A litigation outlook" provides our point of view on 2020, including the key decisions from 2019 that provide a window into what this year holds in store. ...more